We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-0.37%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$105M
(+87%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
51.41%
Top 10 Holdings %
Top 10 Hldgs %
12.31%
Holding
640
New
343
Increased
59
Reduced
31
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$3.45M |
| 2 |
Verizon
VZ
|
+$2.43M |
| 3 |
Veeva Systems
VEEV
|
+$2.32M |
| 4 |
BCOV
Brightcove, Inc.
BCOV
|
+$2.12M |
| 5 |
Tractor Supply
TSCO
|
+$1.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$1.72M |
| 2 |
Visa
V
|
+$1.43M |
| 3 |
Accenture
ACN
|
+$1.21M |
| 4 |
INST
Instructure Holdings, Inc.
INST
|
+$1.11M |
| 5 |
Amphenol
APH
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.62% |
| 2 | Technology | 14.02% |
| 3 | Healthcare | 13.43% |
| 4 | Financials | 13.11% |
| 5 | Consumer Discretionary | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
MacroGenics
MGNX
$257M
| $89.1K | 0.04% |
+27,410
| New | +$98.7K |
|
|
EWCZ
402
DELISTED
European Wax Center
EWCZ
| $87.6K | 0.04% |
+13,133
| New | +$86.4K |
|
|
TERN
403
DELISTED
Terns Pharmaceuticals
TERN
| $85.6K | 0.04% |
+15,456
| New | +$105K |
|
404
Prospect Capital
PSEC
$1.17B
| $84.3K | 0.04% |
+19,561
| New | +$93.8K |
|
405
Ardelyx
ARDX
$997M
| $80K | 0.04% |
+15,781
| New | +$87.2K |
|
406
Butterfly Network
BFLY
$2.35B
| $78.8K | 0.04% |
+25,241
| New | +$65.7K |
|
|
DCH
407
Dauch Corp
DCH
$1.51B
| $76.3K | 0.03% |
+13,095
| New | +$81.9K |
|
408
GoodRx Holdings
GDRX
$1.26B
| $75.4K | 0.03% |
+16,210
| New | +$89.1K |
|
409
Pitney Bowes
PBI
$2.39B
| $74.1K | 0.03% |
10,238
-10,052
| -50% | -$74.7K |
|
410
iHeartMedia
IHRT
$583M
| $72.4K | 0.03% |
+36,590
| New | +$77.4K |
|
411
Ring Energy
REI
$339M
| $72.3K | 0.03% |
+53,164
| New | +$79.8K |
|
412
Puma Biotechnology
PBYI
$454M
| $71.6K | 0.03% |
+23,484
| New | +$68.3K |
|
413
Talkspace
TALK
$874M
| $71.5K | 0.03% |
+23,135
| New | +$70.4K |
|
414
Marqeta
MQ
$1.66B
| $65K | 0.03% |
+4,285
| New | +$75.2K |
|
415
Coeur Mining
CDE
$17.9B
| $64.2K | 0.03% |
11,228
-4,568
| -29% | -$29.6K |
|
416
Voyager Therapeutics
VYGR
$201M
| $60.4K | 0.03% |
+10,646
| New | +$68.6K |
|
|
EXK
417
Endeavour Silver
EXK
$2.83B
| $57.1K | 0.03% |
+15,599
| New | +$68.9K |
|
418
Petco
WOOF
$794M
| $56.2K | 0.03% |
+14,738
| New | +$66.6K |
|
419
BuzzFeed
BZFD
$96.7M
| $55.5K | 0.02% |
+20,769
| New | +$65.2K |
|
|
SVM
420
Silvercorp Metals
SVM
$2.53B
| $54.2K | 0.02% |
+18,078
| New | +$71.3K |
|
421
Oil States International
OIS
$491M
| $52.6K | 0.02% |
+10,394
| New | +$51.8K |
|
422
Zentalis Pharmaceuticals
ZNTL
$302M
| $51.9K | 0.02% |
+17,134
| New | +$56.2K |
|
423
LifeMD
LFMD
$172M
| $51.7K | 0.02% |
+10,443
| New | +$54.7K |
|
|
OGI
424
Organigram Holdings
OGI
$139M
| $50.5K | 0.02% |
+31,347
| New | +$51.1K |
|
425
Hyliion Holdings
HYLN
$690M
| $49.6K | 0.02% |
+18,992
| New | +$52.8K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Oxford Asset Management held 640 positions worth $225M, up 87% from $120M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oxford Asset Management deployed $116M of net new capital in Q4 2024, opening 343 new positions and adding to 59 existing holdings. Its largest new stake was Avid Bioservices, Inc. Common Stock: 301,218 shares worth $3.72M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was McKesson, an estimated $773K trimmed.
- Oxford Asset Management's largest Q4 2024 buy was Avid Bioservices, Inc. Common Stock: 301,218 shares worth $3.72M.
- Oxford Asset Management added most to State Street SPDR S&P Biotech ETF in Q4 2024, an estimated $1.92M increase.
- Oxford Asset Management's biggest Q4 2024 reduction was McKesson, cutting an estimated $773K.
- Oxford Asset Management fully exited TJX Companies in Q4 2024, selling an estimated $1.72M.
- Oxford Asset Management's ten largest holdings make up 12% of its $225M portfolio in Q4 2024.
- Oxford Asset Management opened 343 new positions and closed 204 in Q4 2024.
- Oxford Asset Management's portfolio value rose 87% quarter-over-quarter to $225M.
Based on Oxford Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.